HIV 1 News and Research

RSS

CBIS initiates CS-TATI-1 GMP development plan

Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical to meet global public health challenges is pleased to announce the initiation of GMP development plan for CS-TATI-1 with the initial production of CS-TATI-1 to be performed in Colorado under C-GMP conditions evaluated by the FDA for initial human studies to treat HIV associated Kaposi Sarcoma.

13 Aug 2012

Fluorescent molecules 'tag' DNA and monitor looping process

In a new study, UT Dallas researchers outline how they used fluorescent molecules to "tag" DNA and monitor a process called DNA looping, a natural biological mechanism involved in rearranging genetic material in some types of cells.

13 Aug 2012

World needs a business plan to end AIDS

In this post in Global Post's "Global Pulse" blog, Mitchell Warren, executive director of AVAC, a leading HIV prevention advocacy organization, and Chris Collins, vice president and director of public policy at amfAR, the Foundation for AIDS Research, write that "the world needs a business plan to end AIDS."

13 Aug 2012

Study assesses gender differences in the efficacy of antiretroviral treatment

Women comprise nearly half of the HIV-infected population worldwide, but these 15.5 million women tend to be under-represented in clinical trials of anti-HIV drug therapies. The U.S. Food and Drug Administration (FDA) has created a database from 40 clinical studies to assess gender differences in the efficacy of antiretroviral treatments.

12 Aug 2012

Evaluating cash transfers as a tool to combat HIV/AIDS

In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, and Denizhan Duran, a research assistant at the center, examine several recent studies evaluating the use of cash transfers as a strategy against HIV/AIDS.

10 Aug 2012

Viewpoints: Romney campaign's response to ad incites conservatives; Opponents of law should give back their rebates

The Romney people are trying a little jujitsu on an ad from Obama backers that implies Mitt Romney is responsible for the death of an Indiana woman who lacked health insurance.

10 Aug 2012

U.S. visa policies kept sex workers, drug users from participating in AIDS 2012

The Center for Global Health Policy's "Science Speaks" blog examines how the "U.S. travel bans on people involved in sex work and people who have used illegal drugs ... kept many of the people at highest risk from coming to the [XIX International AIDS Conference (AIDS 2012)]" in Washington, D.C., last month. "

10 Aug 2012

New York Times blog examines gap in surgical care in developing world

In this post in the New York Times' "Opinionator" blog, journalist Sarika Bansal reports on a gap in surgical care in developing countries, writing, "It is conservatively estimated that 56 million people in sub-Saharan Africa -- over twice the number living with HIV/AIDS -- need a surgery today," but, "across the developing world, surgical care often does not reach those who need it."

10 Aug 2012

Protecting human rights of women living with HIV

"Women who are living with HIV remain particularly vulnerable to human rights abuses, including unlawful breaches of confidentiality, denial of health services, compulsory HIV testing and in some cases forced sterilization," a UNAIDS feature story reports

10 Aug 2012

IRIN examines administration of methadone as treatment for people who inject drugs in Bangladesh

"Methadone treatment is proving to be the most efficient way to wean people in Bangladesh from addiction to buprenorphine, a pharmaceutical drug, and health experts say it should be expanded to reach thousands more drug users to prevent the spread of HIV," IRIN reports.

10 Aug 2012

South Africa to become first PEPFAR country to 'nationalize' AIDS program

"U.S. Secretary of State Hillary Clinton said during a visit to South Africa that Pretoria will begin taking more of the responsibilities for its HIV/AIDS program, part of a broader effort to overhaul the U.S. global plan for AIDS relief launched under former President George W. Bush," Reuters reports.

9 Aug 2012

New HIV test helps researchers determine incidence, whether prevention strategies work

The Centers for Disease Control and Prevention (CDC) has developed a new HIV test, called the Limiting Antigen Avidity Enzyme Immunoassay, that can tell whether a person contracted the virus within the last 141 days, "hugely important information for researchers, who need to know whether fewer people are becoming newly infected with HIV to determine whether a prevention program is working," the Wall Street Journal's "Health Blog" reports.

9 Aug 2012

Immigration influences HIV diagnosis demographics

HIV-positive individuals born outside the USA are a heterogenous population but have significant demographic differences to infected patients born within in the USA, research reveals.

8 Aug 2012

UAB program helps reduce incidence of HIV/AIDS in the U.S.

In the year since the University of Alabama at Birmingham emergency department began offering HIV screening for all patients ages 19-64, doctors say 20,000 tests were performed and 72 cases of HIV infection were diagnosed.

8 Aug 2012

Malawi launches week-long campaign to test 250,000 people for HIV

"Malawi on Monday launched a week-long campaign to test 250,000 people for HIV in what health authorities called a crucial intervention in a country ravaged by AIDS," Agence France-Presse reports.

8 Aug 2012

Clinton discusses global HIV efforts with South African officials during 11-day African tour

U.S. Secretary of State Hillary Clinton on Tuesday visited officials in South Africa and discussed the response to HIV/AIDS, the Associated Press/Huffington Post reports. Speaking with Foreign Minister Maite Nkoana-Mashabane "in the second cabinet-level strategic dialogue between the two nations," Clinton said "that global efforts to stop the virus 'have saved hundreds of thousands of lives,'" the news service writes.

8 Aug 2012

Article describes feasibility and costs of active tuberculosis case finding project in Cape Town

A research article by Katharina Kranzer from the London School of Hygiene & Tropical Medicine and colleagues describe the feasibility and costs of an active tuberculosis case finding project in Cape Town, South Africa.

8 Aug 2012

GeneXpert TB test maker Cepheid signs deals with PEPFAR, USAID, others to provide lower-cost kits

Diagnostics company Cepheid on Monday signed deals with PEPFAR, USAID, UNITAID, and the Bill & Melinda Gates Foundation to immediately reduce the price of its Xpert MTB/RIF test kit for its GeneXpert tuberculosis (TB) diagnostic system in 145 countries, Reuters reports.

8 Aug 2012

BioDiem granted European patent for antimicrobial drug

Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.

7 Aug 2012

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

BioDiem recently signed a collaborative agreement with The Royal Melbourne Institute of Technology (RMIT) for the development of non-influenza vaccines using BioDiem’s proprietary live attenuated influenza virus (LAIV) technology.

7 Aug 2012